Claudio Castillo

782 total citations
16 papers, 536 citations indexed

About

Claudio Castillo is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Modeling and Simulation. According to data from OpenAlex, Claudio Castillo has authored 16 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 4 papers in Modeling and Simulation. Recurrent topics in Claudio Castillo's work include Opioid Use Disorder Treatment (7 papers), Substance Abuse Treatment and Outcomes (6 papers) and COVID-19 epidemiological studies (4 papers). Claudio Castillo is often cited by papers focused on Opioid Use Disorder Treatment (7 papers), Substance Abuse Treatment and Outcomes (6 papers) and COVID-19 epidemiological studies (4 papers). Claudio Castillo collaborates with scholars based in Spain, Chile and Sweden. Claudio Castillo's co-authors include Marta Torrens, Antònia Domingo‐Salvany, Luis San, Víctor Pérez, Matilde Maddaleno, Pablo Villalobos Dintrans, Rafael de la Torre, M. Teresa Brugal, Silvia Martín and Francina Fonseca and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Environmental Research and Public Health.

In The Last Decade

Claudio Castillo

16 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Castillo Spain 11 280 226 59 57 56 16 536
Nicola Metrebian United Kingdom 11 492 1.8× 479 2.1× 57 1.0× 90 1.6× 67 1.2× 32 734
Seyed Ramin Radfar Iran 10 253 0.9× 131 0.6× 14 0.2× 24 0.4× 60 1.1× 27 459
Linda Montanari Portugal 13 219 0.8× 115 0.5× 22 0.4× 54 0.9× 55 1.0× 34 380
Mas Ayu Said Malaysia 16 98 0.3× 123 0.5× 120 2.0× 21 0.4× 36 0.6× 42 694
Joshua Sharfstein United States 10 121 0.4× 205 0.9× 8 0.1× 53 0.9× 28 0.5× 19 459
Arun Kandasamy India 13 134 0.5× 119 0.5× 78 1.3× 34 0.6× 51 0.9× 51 535
Brian Chan United States 15 346 1.2× 294 1.3× 54 0.9× 72 1.3× 48 0.9× 43 810
Kuo-Cherh Huang Taiwan 9 48 0.2× 140 0.6× 56 0.9× 85 1.5× 15 0.3× 19 499
Michelle Hall Australia 7 138 0.5× 111 0.5× 32 0.5× 28 0.5× 101 1.8× 8 329
Maria Speed Denmark 7 106 0.4× 72 0.3× 44 0.7× 17 0.3× 27 0.5× 19 402

Countries citing papers authored by Claudio Castillo

Since Specialization
Citations

This map shows the geographic impact of Claudio Castillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Castillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Castillo more than expected).

Fields of papers citing papers by Claudio Castillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Castillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Castillo. The network helps show where Claudio Castillo may publish in the future.

Co-authorship network of co-authors of Claudio Castillo

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Castillo. A scholar is included among the top collaborators of Claudio Castillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Castillo. Claudio Castillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vallecillo, Gabriel, et al.. (2022). Similar COVID-19 incidence to the general population in people with opioid use disorder receiving integrated outpatient clinical care. SHILAP Revista de lepidopterología. 2. 100027–100027. 2 indexed citations
2.
Vargas, Claudio, et al.. (2022). Factors associated with change in adherence to COVID-19 personal protection measures in the Metropolitan Region, Chile. PLoS ONE. 17(5). e0267413–e0267413. 3 indexed citations
3.
Castillo, Claudio, Pablo Villalobos Dintrans, & Matilde Maddaleno. (2021). The successful COVID-19 vaccine rollout in Chile: Factors and challenges. Vaccine X. 9. 100114–100114. 37 indexed citations
4.
Dintrans, Pablo Villalobos, et al.. (2021). COVID-19 incidence and mortality in the Metropolitan Region, Chile: Time, space, and structural factors. PLoS ONE. 16(5). e0250707–e0250707. 21 indexed citations
5.
Dintrans, Pablo Villalobos, et al.. (2021). Identification of COVID-19 Waves: Considerations for Research and Policy. International Journal of Environmental Research and Public Health. 18(21). 11058–11058. 31 indexed citations
6.
Hogg, Bridget, Joaquim Raduà, Aleix Solanes, et al.. (2020). Traumatic Events in Dual Disorders: Prevalence and Clinical Characteristics. Journal of Clinical Medicine. 9(8). 2553–2553. 7 indexed citations
7.
Torrens, Marta, Francina Fonseca, Claudio Castillo, & Antònia Domingo‐Salvany. (2015). Opioid substitution treatment in Spain: 20 years of experience in harm reduction programs. Drug and Alcohol Dependence. 156. e223–e223. 1 indexed citations
8.
Torrens, Marta, Francina Fonseca, Claudio Castillo, & Antònia Domingo‐Salvany. (2013). Methadone maintenance treatment in Spain: the success of a harm reduction approach. Bulletin of the World Health Organization. 91(2). 136–141. 38 indexed citations
9.
Domingo‐Salvany, Antònia, et al.. (2004). Characteristics of Heroin Addicts Entering Methadone Maintenance Treatment: Quality of Life and Gender. Substance Use & Misuse. 39(9). 1353–1368. 95 indexed citations
10.
Castillo, Claudio, et al.. (2004). Medical Assessment in Drug Addicts: Reliability and Validity of the Cumulative Illness Rating Scale (Substance Abuse Version). European Addiction Research. 10(3). 112–117. 9 indexed citations
11.
Torrens, Marta, et al.. (1998). Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program. Drug and Alcohol Dependence. 52(3). 193–200. 30 indexed citations
12.
Torrens, Marta, et al.. (1997). Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction. 92(6). 707–716. 90 indexed citations
13.
Torrens, Marta, Luís San, Alba Martínez-Escudé, et al.. (1997). Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction. 92(6). 707–716. 10 indexed citations
14.
Torrens, Marta, Claudio Castillo, & Víctor Pérez. (1996). Retention in a low-threshold methadone maintenance program. Drug and Alcohol Dependence. 41(1). 55–59. 71 indexed citations
15.
San, Luis, Marta Torrens, Claudio Castillo, Miquel Porta, & Rafael de la Torre. (1993). Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross–sectional studies in 1988 and 1990. Addiction. 88(10). 1341–1349. 37 indexed citations
16.
San, Luis, et al.. (1993). Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification. Drug and Alcohol Dependence. 32(3). 281–286. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026